IRWD Earnings Ironwood Pharmaceuticals Inc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–54 of 54
| Q2 2026 | 2026-06-30 | 0.31 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.24 | 2026-05-07 | 10-Q |
| Q4 2025 | 2025-12-31 | -0.01 | 2026-02-26 | 10-K |
| FY 2025 | 2025-12-31 | 0.15 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | 0.23 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.14 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.23 | 2025-05-12 | 10-Q |
| Q4 2024 | 2024-12-31 | 0.01 | 2025-03-31 | 10-K |
| FY 2024 | 2024-12-31 | 0.01 | 2025-03-31 | 10-K |
| Q3 2024 | 2024-09-30 | 0.02 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.01 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.03 | 2024-05-09 | 10-Q |
| Q4 2023 | 2023-12-31 | -0.01 | 2024-02-16 | 10-K |
| FY 2023 | 2023-12-31 | -6.45 | 2024-02-16 | 10-K |
| Q3 2023 | 2023-09-30 | 0.09 | 2023-11-09 | 10-Q |
| Q2 2023 | 2023-06-30 | -6.84 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | 0.25 | 2023-05-04 | 10-Q |
| Q4 2022 | 2022-12-31 | 0.27 | 2023-02-16 | 10-K |
| FY 2022 | 2022-12-31 | 0.96 | 2023-02-16 | 10-K |
| Q3 2022 | 2022-09-30 | 0.28 | 2022-11-03 | 10-Q |
| Q1 2022 | 2022-06-30 | 0.21 | 2022-08-04 | 10-Q |
| Q1 2022 | 2022-03-31 | 0.21 | 2022-05-05 | 10-Q |
| Q4 2021 | 2021-12-31 | 0.25 | 2022-02-18 | 10-K |
| FY 2021 | 2021-12-31 | 3.21 | 2022-02-18 | 10-K |
| Q3 2021 | 2021-09-30 | 0.34 | 2021-11-04 | 10-Q |
| Q2 2021 | 2021-06-30 | 2.39 | 2021-08-05 | 10-Q |
| Q1 2021 | 2021-03-31 | 0.25 | 2021-05-06 | 10-Q |
| Q4 2020 | 2020-12-31 | 0.27 | 2021-02-17 | 10-K |
| FY 2020 | 2020-12-31 | 0.66 | 2021-02-17 | 10-K |
| Q3 2020 | 2020-09-30 | 0.21 | 2020-11-05 | 10-Q |
| Q2 2020 | 2020-06-30 | 0.16 | — | — |
| Q1 2020 | 2020-03-31 | 0.02 | — | — |
| Q4 2019 | 2019-12-31 | 0.30 | 2020-02-13 | 10-K |
| FY 2019 | 2019-12-31 | 0.14 | 2020-02-13 | 10-K |
| Q3 2019 | 2019-09-30 | 0.13 | — | — |
| Q2 2019 | 2019-06-30 | 0.08 | — | — |
| Q1 2019 | 2019-03-31 | -0.38 | — | — |
| FY 2018 | 2018-12-31 | -1.85 | — | — |
| Q4 2013 | 2013-12-31 | -0.43 | 2014-02-07 | 10-K |
| FY 2013 | 2013-12-31 | -2.35 | 2014-02-07 | 10-K |
| Q3 2013 | 2013-09-30 | -0.51 | 2013-10-28 | 10-Q |
| Q2 2013 | 2013-06-30 | -0.57 | — | — |
| Q1 2013 | 2013-03-31 | -0.87 | — | — |
| Q4 2012 | 2012-12-31 | -0.41 | 2013-02-21 | 10-K |
| FY 2012 | 2012-12-31 | -0.68 | 2013-02-21 | 10-K |
| Q3 2012 | 2012-09-30 | 0.42 | 2012-11-06 | 10-Q |
| Q2 2012 | 2012-06-30 | -0.38 | — | — |
| Q1 2012 | 2012-03-31 | -0.34 | — | — |
| Q4 2011 | 2011-12-31 | -0.07 | — | — |
| FY 2011 | 2011-12-31 | -0.65 | — | — |
| Q3 2011 | 2011-09-30 | -0.21 | — | — |
| Q2 2011 | 2011-06-30 | -0.19 | 2011-08-12 | 10-Q |
| Q1 2011 | 2011-03-31 | -0.19 | — | — |
| Q2 2010 | 2010-06-30 | -0.18 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.